Emergent BioSolutions Inc.

DB:ER4 Stock Report

Market Cap: €490.3m

Emergent BioSolutions Future Growth

Future criteria checks 4/6

Emergent BioSolutions's revenue is forecast to decline at 0.7% per annum while its annual earnings are expected to grow at 98.5% per year. EPS is expected to grow by 98.6% per annum. Return on equity is forecast to be 28.4% in 3 years.

Key information

98.5%

Earnings growth rate

98.6%

EPS growth rate

Biotechs earnings growth42.4%
Revenue growth rate-0.7%
Future return on equity28.4%
Analyst coverage

Low

Last updated07 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:ER4 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,08113N/AN/A1
12/31/20251,196491661831
12/31/20241,108-182146601
9/30/20241,126-209138171N/A
6/30/20241,102-5873177N/A
3/31/20241,185-565-138-85N/A
12/31/20231,049-760-264-206N/A
9/30/20231,103-778-216-146N/A
6/30/20231,072-602-602-280N/A
3/31/2023974-394-523-181N/A
12/31/20221,118-212-394-34N/A
9/30/20221,49133-180201N/A
6/30/20221,58188127292N/A
3/31/20221,75715878279N/A
12/31/20211,77422096320N/A
9/30/20211,65322723237N/A
6/30/20211,709299121326N/A
3/31/20211,706387300483N/A
12/31/20201,577306385537N/A
9/30/20201,333167262413N/A
6/30/20201,259170184305N/A
3/31/20201,1086841141N/A
12/31/20191,1065591188N/A
9/30/20191,0164-181-100N/A
6/30/2019878-18-1577N/A
3/31/20198554266148N/A
12/31/201878263-3042N/A
9/30/2018706100221285N/A
6/30/2018681113N/A146N/A
3/31/201856267N/A165N/A
12/31/201756183N/A208N/A
9/30/201751981N/A118N/A
6/30/201751268N/A110N/A
3/31/201750361N/A54N/A
12/31/201648963N/A55N/A
9/30/201649773N/A70N/A
6/30/201651294N/A148N/A
3/31/2016529125N/A153N/A
12/31/201548991N/A43N/A
9/30/201547879N/A93N/A
6/30/201545759N/A67N/A
3/31/201546035N/A76N/A
12/31/201440454N/A112N/A
9/30/201440022N/A69N/A
6/30/201435114N/A50N/A
3/31/201432419N/A72N/A
12/31/201331331N/A97N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ER4 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).

Earnings vs Market: ER4 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: ER4 is expected to become profitable in the next 3 years.

Revenue vs Market: ER4's revenue is expected to decline over the next 3 years (-0.7% per year).

High Growth Revenue: ER4's revenue is forecast to decline over the next 3 years (-0.7% per year).

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ER4's Return on Equity is forecast to be high in 3 years time (28.4%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y